HAL (France)open access
Trial watch: antibody-drug conjugates in cancer therapy
Bystander effect, Topoisomerase I inhibitor, Cancer immunotherapy, Immunogenic cell death, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 205878
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.